Saturday, May 17, 2025
wellness India Expo
Home Tags MPNs

Tag: MPNs

Merck to acquire Imago BioSciences for US$1.35 billion

Imago is a clinical stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms (MPNs) and other bone marrow diseases